Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 7
1970 1
1971 8
1972 3
1976 2
1977 2
1978 2
1979 1
1980 2
1981 1
1982 1
1985 2
1987 1
1998 1
1999 2
2000 2
2001 9
2002 8
2003 8
2004 10
2005 6
2006 20
2007 59
2008 79
2009 83
2010 72
2011 80
2012 88
2013 75
2014 100
2015 108
2016 86
2017 129
2018 105
2019 77
2020 30
Text availability
Article attribute
Article type
Publication date

Search Results

1,156 results
Results by year
Filters applied: . Clear all
Page 1
Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.
Martínez-Lavín M, Amezcua-Guerra L. Martínez-Lavín M, et al. Clin Rheumatol. 2017 Oct;36(10):2169-2178. doi: 10.1007/s10067-017-3768-5. Epub 2017 Jul 20. Clin Rheumatol. 2017. PMID: 28730271 Review.
Most HPV vaccine randomized trials did not use inert placebo in the control group. Two of the largest randomized trials found significantly more severe adverse events in the tested HPV vaccine arm of the study. ...Two of the largest randomized …
Most HPV vaccine randomized trials did not use inert placebo in the control group. Two of the largest randomized trials found …
HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature.
Genovese C, LA Fauci V, Squeri A, Trimarchi G, Squeri R. Genovese C, et al. J Prev Med Hyg. 2018 Sep 28;59(3):E194-E199. doi: 10.15167/2421-4248/jpmh2018.59.3.998. eCollection 2018 Sep. J Prev Med Hyg. 2018. PMID: 30397675 Free PMC article.
BACKGROUND: In the literature conflicting opinions are detectable on the onset of adverse events as autoimmune disease post HPV vaccine and often case reports describes the onset of one of these events, but don't emerge a clear relationship and we don't have …
BACKGROUND: In the literature conflicting opinions are detectable on the onset of adverse events as autoimmune disease post HPV
No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?
Tomljenovic L, Shaw CA. Tomljenovic L, et al. J Intern Med. 2012 Nov;272(5):514-5; author reply 516. doi: 10.1111/j.1365-2796.2012.02551.x. Epub 2012 May 24. J Intern Med. 2012. PMID: 22540172 Free article. No abstract available.
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.
Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D. Giuliano AR, et al. N Engl J Med. 2011 Feb 3;364(5):401-11. doi: 10.1056/NEJMoa0909537. N Engl J Med. 2011. PMID: 21288094 Free PMC article. Clinical Trial.
BACKGROUND: Infection with human papillomavirus (HPV) and diseases caused by HPV are common in boys and men. We report on the safety of a quadrivalent vaccine (active against HPV types 6, 11, 16, and 18) and on its efficacy in preventing the dev …
BACKGROUND: Infection with human papillomavirus (HPV) and diseases caused by HPV are common in boys and men. We report …
HPV vaccine implementation and monitoring in Latin America.
Luciani S, Bruni L, Agurto I, Ruiz-Matus C. Luciani S, et al. Salud Publica Mex. 2018 Nov-Dic;60(6):683-692. doi: 10.21149/9090. Salud Publica Mex. 2018. PMID: 30699273 Review. English.
Although Latin America is the most advanced developing region with HPV vaccine introduction, systems for its monitoring are weak and there is a paucity of consistently available coverage data for this vaccine. Challenges remain to introduce HPV vacc
Although Latin America is the most advanced developing region with HPV vaccine introduction, systems for its monitoring are we …
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.
Giuliano AR, Joura EA, Garland SM, Huh WK, Iversen OE, Kjaer SK, Ferenczy A, Kurman RJ, Ronnett BM, Stoler MH, Bautista OM, Moeller E, Ritter M, Shields C, Luxembourg A. Giuliano AR, et al. Gynecol Oncol. 2019 Jul;154(1):110-117. doi: 10.1016/j.ygyno.2019.03.253. Epub 2019 Apr 11. Gynecol Oncol. 2019. PMID: 30982556 Free article. Clinical Trial.
OBJECTIVE: Nine-valent human papillomavirus (9vHPV) vaccine efficacy against disease and cervical surgeries related to all nine vaccine components was assessed compared with a historic placebo population. This was not assessed in the 9vHPV vaccine effi …
OBJECTIVE: Nine-valent human papillomavirus (9vHPV) vaccine efficacy against disease and cervical surgeries related to all nin …
Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine.
Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Adjei Boakye E, et al. Hum Vaccin Immunother. 2017 Nov 2;13(11):2713-2722. doi: 10.1080/21645515.2017.1363133. Epub 2017 Aug 30. Hum Vaccin Immunother. 2017. PMID: 28853980 Free PMC article.
Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We assessed racial/ethnic and gender disparities in knowledge and awareness of HPV and the HPV vaccine among US adults. ...RESULTS: Sixty-six percent of respondent …
Purpose: Gaps remain in the public's knowledge of the human papillomavirus (HPV). We assessed racial/ethnic and gender dispari …
Suspected adverse effects after human papillomavirus vaccination: a temporal relationship.
Ikeda SI, Hineno A, Ozawa K, Kinoshita T. Ikeda SI, et al. Immunol Res. 2018 Dec;66(6):723-725. doi: 10.1007/s12026-018-9063-y. Immunol Res. 2018. PMID: 30719604 Review.
Later, these symptoms were supposed to be adverse effects after HPV vaccination, and the recommendation for HPV vaccination was withdrawn by Japanese Ministry of Public Health, Labour and Welfare 4years and 9months ago. However, a causal link has not b …
Later, these symptoms were supposed to be adverse effects after HPV vaccination, and the recommendation for HPV
HPV vaccines: a controversial issue?
Nicol AF, Andrade CV, Russomano FB, Rodrigues LL, Oliveira NS, Provance DW Jr. Nicol AF, et al. Braz J Med Biol Res. 2016;49(5):e5060. doi: 10.1590/1414-431X20155060. Epub 2016 Apr 8. Braz J Med Biol Res. 2016. PMID: 27074168 Free PMC article. Review.
The most common reason for not administering the prophylactic HPV vaccines are concerns over adverse effects. The aim of this review is the assessment of peer-reviewed scientific data related to measurable outcomes from the use of HPV vaccine
The most common reason for not administering the prophylactic HPV vaccines are concerns over adverse effects. Th …
No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study.
Suzuki S, Hosono A. Suzuki S, et al. Papillomavirus Res. 2018 Jun;5:96-103. doi: 10.1016/j.pvr.2018.02.002. Epub 2018 Feb 23. Papillomavirus Res. 2018. PMID: 29481964 Free PMC article.
However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse events. ...The results suggest no causal association between the HPV vaccines and reported symptoms....
However, in June 2013, the Ministry suspended proactive recommendation of the vaccine after unconfirmed reports of adverse eve …
1,156 results
Jump to page
Feedback